SEX DIFFERENCES IN PLASMA CLOZAPINE/NORCLOZAPINE AND OLANZAPINE CONCENTRATIONS IN CLINICAL PRACTICE: DATA FROM A THERAPEUTIC DRUGMONITORING SERVICE

被引：1
|
作者：
Couchman, Lewis [1 ]
Bowskill, Sally V. [1 ]
MacCabe, James H. [2 ]
Patel, Maxine X. [2 ]
Flanagan, Robert J. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust London, Dept Clin Biochem, Toxicol Unit, London, England
[2] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England
来源：
SCHIZOPHRENIA RESEARCH | 2012年 / 136卷
关键词：
D O I：
10.1016/S0920-9964(12)70576-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
4
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [21] Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010
    Bowskill, Sally
    Couchman, Lewis
    MacCabe, James Hunter
    Flanagan, Robert James
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (03) : 277 - 283
  • [22] Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data
    Ding, Jing
    Zhang, Yan
    Zhang, Yan
    Yang, Liu
    Zhang, Suo
    Cui, Xiaohua
    Meng, Zhuocheng
    Li, Yajuan
    Xing, Huan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (06) : 552 - 559
  • [23] Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18years: data from a therapeutic drug monitoring service, 1994-2010
    Couchman, Lewis
    Bowskill, Sally V. J.
    Handley, Simon
    Patel, Maxine X.
    Flanagan, Robert J.
    EARLY INTERVENTION IN PSYCHIATRY, 2013, 7 (02) : 122 - 130
  • [24] Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients
    Ansermot, Nicolas
    Vathanarasa, Harish
    Ranjbar, Setareh
    Gholam, Mehdi
    Crettol, Severine
    Vandenberghe, Frederik
    Gamma, Franziska
    Plessen, Kerstin Jessica
    von Gunten, Armin
    Conus, Philippe
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2024, 46 (06) : 828 - 836
  • [25] THERAPEUTIC ADVANTAGES OF MONITORING PLASMA-CONCENTRATIONS OF PERPHENAZINE IN CLINICAL-PRACTICE
    HANSEN, LB
    LARSEN, NE
    PSYCHOPHARMACOLOGY, 1985, 87 (01) : 16 - 19
  • [26] Plasma Olanzapine in Relation to Prescribed Dose and Other Factors Data From a Therapeutic Drug Monitoring Service, 1999-2009
    Patel, Maxine X.
    Bowskill, Sally
    Couchman, Lewis
    Lay, Victoria
    Taylor, David
    Spencer, Edgar Pathrose
    Flanagan, Robert James
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (04) : 411 - 417
  • [27] Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) service
    Waldschmitt, C.
    Vogel, F.
    Maurer, C.
    Hiemke, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 191 - 191
  • [28] OLANZAPINE PLASMA CONCENTRATION AND DOSE: FINDINGS FROM A 10 YEAR REVIEW OF A THERAPEUTIC MONITORING SERVICE
    Patel, M. X.
    Bowskill, S.
    Couchman, L.
    Lay, V
    Taylor, D.
    Spencer, E. P.
    Flanagan, R. J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (08) : A66 - A66
  • [29] OLANZAPINE PLASMA LEVELS AND DOSE: FINDINGS FROM A 10 YEAR REVIEW OF A THERAPEUTIC DRUG MONITORING SERVICE
    Patel, Maxine X.
    Bowskill, S.
    Couchman, L.
    Lay, V.
    Taylor, D.
    Flanagan, R. J.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 317 - 317
  • [30] Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010
    Bowskill, Sally V. J.
    Patel, Maxine X.
    Handley, Simon A.
    Flanagan, Robert J.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (05) : 507 - 513
12345